Pacific Biosciences of California, Inc. (PACB)
After hours:
| Previous close | 1.6600 |
| Open | 1.7000 |
| Bid | 1.6900 x 2700 |
| Ask | 1.7400 x 300 |
| Day's range | 1.5900 - 1.7500 |
| 52-week range | 1.1600 - 11.9600 |
| Volume | |
| Avg. volume | 9,108,717 |
| Market cap | 474.2M |
| Beta (5Y monthly) | 2.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5000 |
| Earnings date | 28 Oct 2024 - 01 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.83 |
Insider MonkeyPacific Biosciences of California, Inc. (PACB): Among the Worst ARK Stocks According to Short Sellers
We recently compiled a list of the 10 Worst ARK Stocks To Buy According To Short Sellers. In this article, we are going to take a look at where Pacific Biosciences of California, Inc. (NASDAQ:PACB) stands against the other ARK stocks. Investing comes in all sizes and flavors. For the risk averse investors that are looking […]
GlobeNewswireRevio to Power Research in Male Infertility and Rare Disease at Münster University Hospital
Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male Infertility ConsortiumMENLO PARK, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with the University Hospital of Münster, to use long-read whole genome sequencing to significantly advance male infertility and rare disease resear
- GlobeNewswire
PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, at 1:05 p.m. Eastern Time. The event will be live-streamed on the company's investors page at investor.pacificbiosciences.com. A replay will be available for at least 30 days following the ev
